Study proves effectiveness of new strategy in pharmaceutical detailing

05-Apr-2007 - Pharmaceutical companies have, in the past, allocated their sales force resources primarily on the basis of doctors' prescription volumes. For many drugs, however, there are also other factors that determine the effectiveness of detailing. The current edition of the Bienentanz Buzz Letter ...

Studies provide a differentiated view of biotech upsurge in developing countries

15-Jan-2007 - Biotech is booming in many (but not all) developing countries, a trend which is reflected by increases not only in research funding, but also in patenting and publishing. In its current edition, the Bienentanz Buzz Letter points to some recent studies which, on the basis of extensive facts, ...

Mergers and acquisitions: Strategic moves forward or frenzies of futile activity?

New biopharmaceutical industry studies shed light on a contentious issue

04-Aug-2005 - Mergers and acquisitions have driven the concentration process that has both shaped and shaken the biopharmaceutical industry during the past 20 years. The current edition of the Bienentanz Buzz Letter reports on the results of two recent biopharmaceutical industry studies conducted by renowned ...

Determining the price of a drug when competition sets in

14-Apr-2005 - Common wisdom has it that a company entering the market with a follow-on drug needs to price its product at a discount to its first-in-class competitor drug. The current edition of the Bienentanz Buzz Letter reports on a new study based on empirical data and economic theory which suggests that ...

Corporate Governance: financially beneficial to R&D intensive companies?

The Bienentanz Buzz Letter reports on the results of some new studies

30-Mar-2005 - Evidence is mounting that Corporate Governance brings about tangible financial benefits for companies. The current edition of the Bienentanz Buzz Letter reports on two comprehensive recent studies that have analysed the effects of a broad range of governance devices and that have determined and ...

Small companies found to be disadvantaged in protecting their patent rights

07-Sep-2004 - Berlin (Germany) - Small companies with small patent portfolios are the most likely to be involved in court action over patent rights, according to a report in the current edition of the Bienentanz Buzz Letter on a recently published study, which is based on data about close to ten thousand US ...